Rapid Detection and control system for Antimicrobial Resistance

Public Procurement of Innovation

The Project

The Project

RaDAR project aims to address the European urgent need of a rapid detection and effective infection control system for antimicrobial resistance (AMR) through the implementation of a value-based cross-border collaborative procurement of innovative solutions. The common identification of the needs by a cross-border group of 4 procurement organisations (from ES, FR and IT) will promote an increased impact of the adopted innovation and will collaboratively give response to the current AMR problem affecting the European Union (EU).

During COVID-19 pandemic situation, the market, and specially SMEs, have demonstrated a great capacity to rapidly give response to the health and societal needs. Due to their intrinsic flexibility, adaptability and capacity to develop technology and generate knowledge, they are currently playing a key role in the rapid and efficient development of innovative solutions to overcome the threat of AMR. RaDAR will leverage from these advances to adopt innovative solutions that will: 1) respond to the AMR increasing problem; 2) provide SMEs access to public tenders/contracts; 3) bring value to the Health system and foster its digital transformation; 4) contribute to decision making of public authorities in alignment with EU Health policies and European Health Emergency Preparedness and Response Authority (HERA); 5) contribute to the Sustainable Development Goals (SDGs).

RaDAR project aims to address the European urgent need of a rapid detection and effective infection control system for antimicrobial resistance (AMR) through the implementation of a value-based cross-border collaborative procurement of innovative solutions. The common identification of the needs by a cross-border group of 4 procurement organisations (from ES, FR and IT) will promote an increased impact of the adopted innovation and will collaboratively give response to the current AMR problem affecting the European Union (EU).

During COVID-19 pandemic situation, the market, and specially SMEs, have demonstrated a great capacity to rapidly give response to the health and societal needs. Due to their intrinsic flexibility, adaptability and capacity to develop technology and generate knowledge, they are currently playing a key role in the rapid and efficient development of innovative solutions to overcome the threat of AMR. RaDAR will leverage from these advances to adopt innovative solutions that will: 1) respond to the AMR increasing problem; 2) provide SMEs access to public tenders/contracts; 3) bring value to the Health system and foster its digital transformation; 4) contribute to decision making of public authorities in alignment with EU Health policies and European Health Emergency Preparedness and Response Authority (HERA); 5) contribute to the Sustainable Development Goals (SDGs).

apid detection and effective infection control system for antimicrobial resistance
apid detection and effective infection control system for antimicrobial resistance

About

The common identification of the needs by a cross-border group of 4 procurement organisations (from ES, FR and IT) will promote an increased impact of the adopted innovation and will collaboratively give response to the current AMR problem affecting the European Union (EU). During COVID-19 pandemic situation, the market, and specially SMEs, have demonstrated a great capacity to rapidly give response to the health and societal needs.

PIN

The buyers group (Resah, ICO, OSAK, and UNINA- DISAP) has published a Prior Information Notice (PIN) to publicise the project and provide an opportunity for potential solution providers to express interest in the forthcoming open market consultation and subsequent procurement.

PIN

The buyers group (Resah, ICO, OSAK, and UNINA- DISAP) has published a Prior Information Notice (PIN) to publicise the project and provide an opportunity for potential solution providers to express interest in the forthcoming open market consultation and subsequent procurement.

About

The common identification of the needs by a cross-border group of 4 procurement organisations (from ES, FR and IT) will promote an increased impact of the adopted innovation and will collaboratively give response to the current AMR problem affecting the European Union (EU). During COVID-19 pandemic situation, the market, and specially SMEs, have demonstrated a great capacity to rapidly give response to the health and societal needs.

Partners

RaDAR is composed of a cross-border Buyers Group composed of 4 public organisations from 3 different European countries (France, Spain and Italy) who will collaboratively work to act as early adopters and promote innovation, through the identification, evaluation and procurement of innovative solutions that will address their common needs related to one of the most important challenges that are currently present in the political agenda in EU and worldwide. Complementarily, a diverse and carefully selected supporting entities will ensure that the Buyers Group execute a procurement of innovative solutions that will meet both Consortium and individual needs.

Partners

RaDAR is composed of a cross-border Buyers Group composed of 4 public organisations from 3 different European countries (France, Spain and Italy) who will collaboratively work to act as early adopters and promote innovation, through the identification, evaluation and procurement of innovative solutions that will address their common needs related to one of the most important challenges that are currently present in the political agenda in EU and worldwide. Complementarily, a diverse and carefully selected supporting entities will ensure that the Buyers Group execute a procurement of innovative solutions that will meet both Consortium and individual needs.

What's New

Please find here the last updates and news from the RaDAR PPI.

Events

Please find here all the events from the RaDAR PPI.

    Newsletter

    Are you interested in receiving the latest news? Subscribing is optional and you can unsubscribe at any time by clicking the link in the footer of our emails.




    We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp’s privacy practices here.

    You can unsubscribe at any time by clicking the link in the footer of our emails. For information about our privacy practices, please visit our website.